Clinical practice. Combination estrogen-progestin oral contraceptives.
Petitti
Diana B
DB
Research and Evaluation Department, Kaiser Permanente Southern California, Pasadena 91188, USA. diana.b.petitti@kp.org
D000328:Adult; D001943:Breast Neoplasms; D002318:Cardiovascular Diseases / Q000139:chemically induced; D003277:Contraceptives, Oral, Combined / Q000009:adverse effects; D004967:Estrogens / Q000009:adverse effects; D005260:Female; D006801:Humans; D010051:Ovarian Neoplasms / Q000517:prevention & control; D017410:Practice Guidelines as Topic; D011372:Progestins / Q000009:adverse effects; D012307:Risk Factors; D019851:Thrombophilia / Q000175:diagnosis
D003277:Contraceptives, Oral, Combined; D004967:Estrogens; D011372:Progestins